American Journal of Ophthalmology
Volume 149, Issue 5 , Pages 777-784, May 2010

Efficacy and Tolerability of Preservative-Free and Preserved Diclofenac and Preserved Ketorolac Eyedrops After Cataract Surgery

  • Saskia M. Maca

      Affiliations

    • Department of Ophthalmology & Optometry, Medical University Vienna, Vienna, Austria
  • ,
  • Michael Amon

      Affiliations

    • Department of Ophthalmology & Optometry, Medical University Vienna, Vienna, Austria
  • ,
  • Oliver Findl

      Affiliations

    • Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom
  • ,
  • Gunal Kahraman

      Affiliations

    • Department of Ophthalmology & Optometry, Medical University Vienna, Vienna, Austria
  • ,
  • Talin Barisani-Asenbauer

      Affiliations

    • Department of Ophthalmology & Optometry, Medical University Vienna, Vienna, Austria
    • Corresponding Author InformationInquiries to Talin Barisani-Asenbauer, Uveitis Unit, Department of Ophthalmology & Optometry, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria

Accepted 4 December 2009. published online 11 February 2010.

Purpose

To compare the anti-inflammatory efficacy and subjective tolerability of preservative-free and preserved diclofenac 0.1% and preserved ketorolac 0.5% eye drops for prophylaxis and management of inflammation after cataract surgery.

Design

Prospective, randomized, investigator-masked, parallel-group, comparative clinical trial.

Methods

One hundred two patients who underwent small-incision phacoemulsification cataract surgery in an institutional setting were assigned randomly to receive preservative-free diclofenac sodium 0.1% (Voltaren ophtha SDU; Novartis Pharma), preserved diclofenac sodium 0.1% (Voltaren ophtha; Novartis Pharma), or preserved ketorolac tromethamine 0.5% (Acular; Pharm Allergan) eyedrops 4 times daily for 4 weeks after surgery. During the 1-month follow-up, anterior chamber flare and mean foveal thickness were evaluated for objective comparison of the anti-inflammatory effect. Ocular tolerability was assessed by observer-based grading of conjunctival hyperemia and ocular discomfort, as well as obtaining subjective ratings of ocular tolerability on a visual analog scale. Distance and near visual acuity and intraocular pressure served as safety measures.

Results

All 3 formulations demonstrated equal anti-inflammatory efficacy as measured by reduction of anterior chamber flare after surgery and prevention of postoperative macular edema. Patients treated with preservative-free diclofenac eyedrops reported significantly better subjective tolerability values (P = .001), were classified as having less ocular discomfort (P < .001), and experienced earlier reduction of postoperative conjunctival hyperemia (P = .029).

Conclusions

Anti-inflammatory efficacy was comparable for all 3 agents. However, preservative-free diclofenac 0.1% eyedrops exhibited a significantly better postoperative subjective and objective tolerability when compared with preserved eyedrops containing ketorolac or diclofenac.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(09)00913-1

doi:10.1016/j.ajo.2009.12.010

American Journal of Ophthalmology
Volume 149, Issue 5 , Pages 777-784, May 2010